Investigating the effects of type 1 diabetes on children's brain health across different ethnic groups.
Longitudinal Evaluation of Neurocognitive Complications in Pediatric Type 1 Diabetes Across Multi-Ethnic Groups—Exploring Risk and Protective Factors
This study is looking at how type 1 diabetes affects the thinking and learning skills of children from different backgrounds, and it aims to find out how things like diet, lifestyle, and diabetes management tools can help them do better in school and in life.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10975238 on NIH RePORTER |
What this research studies
This research focuses on understanding how type 1 diabetes (T1D) affects neurocognitive development in children from various ethnic backgrounds. The study will track a diverse group of children diagnosed with T1D, examining factors like nutrition, lifestyle, and environmental influences that may impact their cognitive function. Additionally, it will assess the role of diabetes management technologies, such as continuous glucose monitors, in promoting better brain health. By identifying both risk and protective factors, the research aims to improve outcomes for children with T1D.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have been newly diagnosed with type 1 diabetes.
Not a fit: Patients who do not have type 1 diabetes or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing type 1 diabetes in children, enhancing their cognitive health and overall quality of life.
How similar studies have performed: Previous research has shown promising results in understanding the cognitive impacts of diabetes in children, suggesting that this approach could yield valuable insights.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Page, Kathleen Alanna — University of Southern California
- Study coordinator: Page, Kathleen Alanna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.